Chemical control of fibrinolysis-thrombolysis
Read Online

Chemical control of fibrinolysis-thrombolysis theory and clinical applications.

  • 205 Want to read
  • ·
  • 88 Currently reading

Published by Wiley-Interscience in New York .
Written in English


  • Fibrinolytic agents.,
  • Antifibrinolytic agents.

Book details:

Edition Notes

Includes bibliographical references.

StatementEdited by Joseph M. Schor.
ContributionsSchor, Joseph M., 1929- ed.
LC ClassificationsRM340 .C45
The Physical Object
Paginationxvi, 328 p.
Number of Pages328
ID Numbers
Open LibraryOL5444709M
ISBN 100471762679
LC Control Number73105389

Download Chemical control of fibrinolysis-thrombolysis


Conformational control by carbinyl hydrogens. Implications and applications; Tuning Microcapsule Shell Thickness and Structure with Silk Fibroin and Nanoparticles for Sustained Release; Metamaterial-Assisted Photobleaching Microscopy with Nanometer Scale Axial ResolutionAuthor: Alfred Burger. This book familiarizes the reader with some recent trends in the theory and practice of thrombolysis. It covers the field of fibrinolysis from the standpoint of basic scientists and clinicians and delivers the state-of-the-art information on the biochemistry and pharmacology of fibrinolysis, as well as related novel methodological and diagnostic tools in the field. An introductory chapter Cited by: 1. Fibrinolysis is subject to precise control because of the actions of multiple activators, inhibitors, and cofactors. 1 In addition, receptors expressed by endothelial, monocytoid, and myeloid cells provide specialized, protected environments where plasmin can be generated without compromise by circulating inhibitors (Fig. 25–1B). 2,3 Beyond.   Proteolytic resistance conferred to fibrin by chemical modifications can also be explained by similar changes in clot morphology. Factor XIIIa (FXIIIa) is a transglutaminase of plasma or platelet origin, known to introduce γ‐glutamyl‐lysine cross‐links between γC‐ and αC‐domains of adjacent fibrin monomers (reviewed in 42).

  Thrombin activatable fibrinolysis inhibitor (TAFI) is a key element in this process as it is able to control the plasmin activity by removing lysine residues in carboxyterminal region thereby preventing positive feedback of the system. Elucidation of the fine control of fibrinolysis under different physiological and pathological haemostatic states will undoubtedly lead to novel therapeutic interventions. Here, we review the fundamental features of intravascular plasmin generation, and consider the major clinical syndromes result-ing from abnormalities in fibrinolysis. Chemical Process Control An Introduction to Theory and Practice - George Stephanopoulos. A great part of the book concerns the discovery of pencillin. The tradition that the penicillium floated in through a window and Chemical Control of Fibrinolysis-Thrombolysis: Theory and Clinical Applications. Ed. Joseph M. Schor, Ph.D. (Pp. ; s.) John Wiley. Atlas of Surgical Techniques. Philip Thorek.

Table of contents for Annals of Clinical Biochemistry: International Journal of Laboratory Medicine, 10, , Author(s): Schor,Joseph M Title(s): Chemical control of fibrinolysis-thrombolysis; theory and clinical applications. Country of Publication: United States Publisher: New York, Wiley-Interscience [c] Description: xvi, p. illus. Language: English ISBN: , LCCN: MeSH: Antifibrinolytic Agents*; Fibrinolysis*; Fibrinolytic Agents* NLM ID: [Book].   Control experiments showed that none of the chemical anti-inhibitors pro- duced a breakdown of the fibrin gel. The effect of chemical anti-inhibitors on the inhibition of plasmin Chloramine T. The effect on tx2-AP, ot2-MG, tXl-AT, and ATIII was most significant at a concentration of 1 mmol/1 of chloramine T. Search the world's most comprehensive index of full-text books. My library.